Search

Your search keyword '"Marrucci, E."' showing total 6 results
Start Over Author "Marrucci, E." Publisher elsevier bv
6 results on '"Marrucci, E."'

1. Immunogenicity and early clinical outcome after two or three doses of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: results from the prospective observational Vax-On-Third study

Author

Nelli, F., primary, Giannarelli, D., additional, Fabbri, A., additional, Silvestri, M.A., additional, Berrios, J. R. Giron, additional, Virtuoso, A., additional, Marrucci, E., additional, Schirripa, M., additional, Mazzotta, M., additional, Onorato, A., additional, Panichi, V., additional, Topini, G., additional, Pessina, G., additional, Natoni, F., additional, Signorelli, C., additional, Chilelli, M.G., additional, Primi, F., additional, and Ruggeri, E.M., additional

Published
2022
Full Text
View/download PDF

2. P-297 Prognostic impact of primary tumor location on synchronous and metachronous colorectal liver metastases: A retrospective monocentric real-life analysis

Author

Signorelli, C., primary, Chilelli, M., additional, Amodio, P., additional, Schirripa, M., additional, Sperduti, I., additional, Santoro, R., additional, Ranalli, T., additional, Pessina, G., additional, Natoni, F., additional, Virtuoso, A., additional, Giron Berrios, J., additional, Mazzotta, M., additional, Nelli, F., additional, Fabbri, M., additional, Primi, F., additional, Marrucci, E., additional, and Ruggeri, E., additional

Published
2022
Full Text
View/download PDF

3. Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study

Author

Nelli, F., primary, Fabbri, A., additional, Onorato, A., additional, Giannarelli, D., additional, Silvestri, M.A., additional, Pessina, G., additional, Giron Berrios, J.R., additional, Virtuoso, A., additional, Marrucci, E., additional, Schirripa, M., additional, Mazzotta, M., additional, Panichi, V., additional, Cercola, P., additional, Signorelli, C., additional, Chilelli, M.G., additional, Primi, F., additional, and Ruggeri, E.M., additional

Published
2022
Full Text
View/download PDF

4. Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study

Author

Ruggeri, E.M., primary, Nelli, F., additional, Fabbri, A., additional, Onorato, A., additional, Giannarelli, D., additional, Giron Berrios, J.R., additional, Virtuoso, A., additional, Marrucci, E., additional, Mazzotta, M., additional, Schirripa, M., additional, Panichi, V., additional, Pessina, G., additional, Signorelli, C., additional, Chilelli, M.G., additional, Primi, F., additional, Natoni, F., additional, Fazio, S., additional, and Silvestri, M.A., additional

Published
2022
Full Text
View/download PDF

5. Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: preliminary results from the prospective observational Vax-On study

Author

Nelli, F., primary, Fabbri, A., additional, Onorato, A., additional, Giannarelli, D., additional, Silvestri, M.A., additional, Giron Berrios, J.R., additional, Virtuoso, A., additional, Marrucci, E., additional, Signorelli, C., additional, Chilelli, M.G., additional, Primi, F., additional, Schirripa, M., additional, Mazzotta, M., additional, and Ruggeri, E.M., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results